Vanguard Group Inc Puma Biotechnology, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,691,720 shares of PBYI stock, worth $18.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,691,720

Previous 3,706,452 0.4%

Holding current value

$18.3 Million

Previous $12.7 Million 48.97%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$3.07 - $5.73 $45,227 - $84,414	-14,732 Reduced 0.4%	3,691,720 $18.9 Million
Q2 2025 Aug 11, 2025	BUY	$2.74 - $3.72 $101,897 - $138,343	37,189 Added 1.01%	3,706,452 $12.7 Million
Q1 2025 May 09, 2025	BUY	$2.76 - $3.88 $71,321 - $100,263	25,841 Added 0.71%	3,669,263 $10.9 Million
Q4 2024 Feb 11, 2025	BUY	$2.42 - $3.39 $17,499 - $24,513	7,231 Added 0.2%	3,643,422 $11.1 Million
Q3 2024 Nov 13, 2024	BUY	$2.25 - $4.03 $83,740 - $149,988	37,218 Added 1.03%	3,636,191 $9.27 Million
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.83 $314,554 - $628,030	107,724 Added 3.09%	3,598,973 $11.7 Million
Q1 2024 May 10, 2024	SELL	$4.29 - $7.4 $1.33 Million - $2.3 Million	-310,832 Reduced 8.18%	3,491,249 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $66,204 - $133,299	29,688 Added 0.79%	3,802,081 $16.5 Million
Q3 2023 Nov 14, 2023	BUY	$2.63 - $4.09 $21,729 - $33,791	8,262 Added 0.22%	3,772,393 $9.92 Million
Q2 2023 Aug 14, 2023	SELL	$2.6 - $3.58 $18,756 - $25,826	-7,214 Reduced 0.19%	3,764,131 $13.3 Million
Q1 2023 May 15, 2023	BUY	$2.21 - $4.82 $403,154 - $879,278	182,423 Added 5.08%	3,771,345 $11.7 Million
Q4 2022 Feb 10, 2023	SELL	$2.12 - $5.08 $73,578 - $176,311	-34,707 Reduced 0.96%	3,588,922 $15.2 Million
Q3 2022 Nov 14, 2022	SELL	$2.27 - $3.84 $17,706 - $29,952	-7,800 Reduced 0.21%	3,623,629 $8.59 Million
Q2 2022 Aug 12, 2022	BUY	$1.64 - $3.3 $269,925 - $543,143	164,589 Added 4.75%	3,631,429 $10.3 Million
Q1 2022 May 13, 2022	SELL	$2.13 - $3.24 $454,429 - $691,244	-213,347 Reduced 5.8%	3,466,840 $9.99 Million
Q4 2021 Feb 14, 2022	BUY	$2.85 - $6.58 $144,648 - $333,961	50,754 Added 1.4%	3,680,187 $11.2 Million
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $287,675 - $407,432	43,390 Added 1.21%	3,629,433 $25.4 Million
Q2 2021 Aug 13, 2021	BUY	$8.98 - $11.6 $32.2 Million - $41.6 Million	3,586,043 New	3,586,043 $32.9 Million

Others Institutions Holding PBYI

# of Institutions

135

Shares Held

35.2M

Call Options Held

264K

Put Options Held

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Puma Biotechnology, Inc. Transaction History